Genome Information Broker (GIB): data retrieval and comparative analysis system for completed microbial genomes and more.

Nucleic Acids Res

Center for Information Biology and DNA Data Bank of Japan, National Institute of Genetics, Yata, Mishima 411-8540, Japan.

Published: January 2002

Genome Information Broker (GIB) is a powerful tool for the study of comparative genomics. GIB allows users to retrieve and display partial and/or whole genome sequences together with the relevant biological annotation. GIB has accumulated all the completed microbial genome and has recently been expanded to include Arabidopsis thaliana genome data from DDBJ/EMBL/GenBank. In the near future, hundreds of genome sequences will be determined. In order to handle such huge data, we have enhanced the GIB architecture by using XML, CORBA and distributed RDBs. We introduce the new GIB here. GIB is freely accessible at http://gib.genes.nig.ac.jp/.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC99149PMC
http://dx.doi.org/10.1093/nar/30.1.66DOI Listing

Publication Analysis

Top Keywords

genome broker
8
broker gib
8
completed microbial
8
genome sequences
8
gib
7
genome
6
gib data
4
data retrieval
4
retrieval comparative
4
comparative analysis
4

Similar Publications

Introduction: The agriculture genomics community has numerous data submission standards available, but the standards for describing and storing single-cell (SC, e.g., scRNA- seq) data are comparatively underdeveloped.

View Article and Find Full Text PDF
Article Synopsis
  • * QSOX2 is crucial for the proper functioning of Growth hormone by facilitating the transit of a signaling protein (STAT5B) into the nucleus, and its deficiency leads to impaired cellular processes and multi-system issues.
  • * The findings suggest that using recombinant insulin-like growth factor-1 could help address the problems caused by the defective QSOX2 gene, potentially improving organ-specific health outcomes.
View Article and Find Full Text PDF

Reporting tumor genomic test results to SEER registries via linkages.

J Natl Cancer Inst Monogr

August 2024

Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Article Synopsis
  • Precision medicine is increasingly important in cancer care, but tumor genomic data has been lacking in the National Cancer Institute's SEER Program, limiting research on molecular subtypes.
  • To improve this, the SEER Program has implemented a centralized process to link cancer cases in their registries with genomic test results from molecular labs, using specialized software and a trusted third party for data handling.
  • Recent linkages have included various OncotypeDX tests and results from other genomic classifiers, which facilitate the research community's access to valuable, de-identified data for cancer studies.
View Article and Find Full Text PDF

Objective: To study whether gynecologic or reproductive disorders show association with trisomic conceptions.

Methods: This nationwide cohort study utilized the Registry of Congenital Malformations to identify women who had a trisomic pregnancy (n = 5784), either with trisomy 13 (T13; n = 351), trisomy 18 (T18; n = 1065) or trisomy 21 (T21; n = 4369) from 1987 to 2018. We used the Finnish Maternity cohort to match the cases to population controls (n = 34 422) on the age, residence, and timing of pregnancy.

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease with skin barrier defects and a misdirected type 2 immune response against harmless antigens. The skin microbiome in AD is characterized by a reduction in microbial diversity with a dominance of staphylococci, including ().

Objective: To assess whether antigens play a role in AD, we screened for candidate allergens and studied the T cell and humoral immune response against the extracellular serine protease (Esp).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!